Safety and Tolerability Study of Cogane™ in Healthy Volunteers and Parkinson's Disease Patients

Inclusion Criteria

• •Male \& Female healthy volunteers aged between 40 and 80 years at the time of informed consent
• •Females of non-childbearing potential
• •General Good Health
• •Male \& Female Parkinson's disease patients aged between 40 and 80 years at the time of informed consent
• •Must have a diagnosis of idiopathic Parkinson's disease according to the UK Parkinson's Disease Society Brain Bank criteria
• •Subjects who are taking Parkinson's disease treatments should be on a stable regimen for at least 4 weeks prior to screening